Automotive and Transportation Automotive and Transportation

Analysis-Trump turbulence stalls large pharma and biotech deals, bankers say


Published on 2025-03-26 07:21:34 - Reuters
  Print publication without navigation

  • By Sabrina Valle NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House economic policies that have roiled markets and set off a global trade war,

The article from MSN discusses how the uncertainty surrounding former President Donald Trump's potential return to office is causing hesitation among large pharmaceutical and biotech companies in pursuing mergers and acquisitions. According to bankers, the fear stems from Trump's previous policies, including his criticism of high drug prices and his push for drug pricing reforms, which could lead to regulatory changes affecting the industry's profitability. This political uncertainty has led to a slowdown in deal-making as companies and investors adopt a wait-and-see approach, wary of the potential policy shifts that could impact their business strategies and valuations. The article highlights that while there is still interest in smaller, less risky deals, the market for significant transactions has cooled, with companies focusing on internal growth and cost management instead.

Read the Full Reuters Article at:
[ https://www.msn.com/en-us/money/economy/analysis-trump-turbulence-stalls-large-pharma-and-biotech-deals-bankers-say/ar-AA1BGCEC ]